Reductions in Serum Lipids with a 4-year Decline in Serum Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid
Overview
Authors
Affiliations
Background: Several epidemiological cross-sectional studies have found positive associations between serum concentrations of lipids and perfluorooctanoic acid (PFOA, or C8). A longitudinal study should be less susceptible to biases from uncontrolled confounding or reverse causality.
Methods: We investigated the association between within-individual changes in serum PFOA and perfluorooctanesulfonic acid (PFOS) and changes in serum lipid levels (low-density lipoprotein [LDL] cholesterol, high-density lipoprotein cholesterol, total cholesterol, and triglycerides) over a 4.4-year period. The study population consisted of 560 adults living in parts of Ohio and West Virginia where public drinking water had been contaminated with PFOA. They had participated in a cross-sectional study in 2005-2006, and were followed up in 2010, by which time exposure to PFOA had been substantially reduced.
Results: Overall serum concentrations of PFOA and PFOS fell by half from initial geometric means of 74.8 and 18.5 ng/mL, respectively, with little corresponding change in LDL cholesterol (mean increase 1.8%, standard deviation 26.6%). However, there was a tendency for people with greater declines in serum PFOA or PFOS to have greater LDL decrease. For a person whose serum PFOA fell by half, the predicted fall in LDL cholesterol was 3.6% (95% confidence interval = 1.5-5.7%). The association with a decline in PFOS was even stronger, with a 5% decrease in LDL (2.5-7.4%).
Conclusions: Our findings from this longitudinal study support previous evidence from cross-sectional studies of positive associations between PFOA and PFOS in serum and LDL cholesterol.
Hall A, Braun J Am J Lifestyle Med. 2025; 19(2):211-229.
PMID: 39981556 PMC: 11836584. DOI: 10.1177/15598276231162802.
Xiao W, Jian G, Ma F, Li H, Yang X, Zhang H Front Cardiovasc Med. 2025; 11():1487956.
PMID: 39850378 PMC: 11754394. DOI: 10.3389/fcvm.2024.1487956.
Zhu L, Liu B, Hu Y, Wang M, Furtado J, Rimm E Environ Health. 2024; 23(1):108.
PMID: 39627728 PMC: 11613683. DOI: 10.1186/s12940-024-01147-2.
Perfluoroalkyl/Polyfluoroalkyl Substances: Links to Cardiovascular Disease Risk.
Schlezinger J, Gokce N Circ Res. 2024; 134(9):1136-1159.
PMID: 38662859 PMC: 11047059. DOI: 10.1161/CIRCRESAHA.124.323697.
Biggeri A, Stoppa G, Facciolo L, Fin G, Mancini S, Manno V Environ Health. 2024; 23(1):42.
PMID: 38627679 PMC: 11022451. DOI: 10.1186/s12940-024-01074-2.